Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed Apr 14, 2015 · 10-K · 104 days after period end · 0001393905-15-000193
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|
| Revenue | — | $70.09K | — |
| Net Income | -$1.54M | -$806.93K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Apr 14, 2015 · 104 d after period end
